Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rhinaris is a specialized brand of nasal care products owned and manufactured by Pharmascience, a leading Canadian pharmaceutical company. The product line focuses on providing relief for nasal dryness and congestion through various formulations, including saline sprays, lubricating gels, and oil-based mists. Rhinaris products are designed to moisturize the nasal passages and maintain the integrity of the nasal mucosa, often used to treat symptoms associated with allergies, colds, and dry environments. The brand is a staple in the Canadian consumer healthcare market and is widely recommended by healthcare professionals for non-medicated nasal relief. Rhinaris Nozoil, one of its flagship products, is unique for its use of sesame oil to provide prolonged lubrication. The brand serves as a key component of Pharmascience's over-the-counter portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhinaris.